Obesity is transforming the pharmaceutical landscape, with GLP-1 therapies driving record-breaking launches, expanding utilization, and new approaches to chronic disease management. Insight Express Series 3 features IQVIA experts exploring the demand, adoption, persistency, shifting patient and prescriber behavior, and multi-indication trends shaping obesity care—offering insights to help life sciences teams prepare for the next wave of innovation.
Feature 1: Unprecedented Launch
GLP-1 therapies like Mounjaro and Zepbound are rewriting the rules of pharmaceutical launches. From patient-driven demand to social media buzz, these drugs shattered records with billions in sales and millions of prescriptions. Discover how consumer-centric strategies and unmet need transformed these launches into historic blockbusters.
Speaker: Anika LaFazia, Consultant, U.S. Thought Leadership & Innovation, IQVIA
Feature 2: Disease Landscape & Comorbid Markets
Obesity is no longer a lifestyle issue—it’s a chronic condition driving a cascade of comorbidities. Learn how GLP-1 therapies are redefining care models, reducing downstream risks, and creating multi-indication opportunities for pharma in a rapidly evolving market.
Speaker: Eric Foster, Managing Principal, U.S. Market Access Strategy Consulting, IQVIA
Feature 3: Comorbidities Driving Utilization
GLP-1 adoption is accelerating, fueled by patients with multiple comorbidities and expanded coverage. Non-diabetes specialists are prescribing at unprecedented rates, signaling a paradigm shift in obesity care. Explore why these therapies are becoming foundational tools in managing complex conditions.
Speaker: Teddy Landsman, Principal, U.S. Market Access Strategy Consulting, IQVIA
Feature 4: Patient Behavior
Behind the GLP-1 hype lies a challenge: persistency. Many patients abandon therapy early, driven by personal goals, systemic friction, and coverage gaps. Understand how behavior impacts ROI and why integrated care models are key to sustaining outcomes.
Speaker: Jeff Thiesen, Managing Principal, U.S. Market Access Strategy Consulting, IQVIA
Related solutions
Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance.
Grow your brand, now and through patent expiry
Gain high value access and increase the profitability of your brands